HUGE congrats to member company, Lung Therapeutics, on their $36 Million Series C financing to advance their clinical pipeline. Lung Therapeutics has been a member of ACC Bioscience Incubator since January 2018 and we are so proud of their success.

Read more via Yahoo Finance